A Trial of CTS-1027 in Interferon-Naive Hepatitis C Patients.

Trial Profile

A Trial of CTS-1027 in Interferon-Naive Hepatitis C Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2012

At a glance

  • Drugs CTS 1027; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Sponsors Conatus Pharmaceuticals
  • Most Recent Events

    • 27 Feb 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 03 Apr 2011 Results presented at the 46th Annual Meeting of the European Association for the Study of the Liver.
    • 04 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top